Cancer Family
Reproductive System Neoplasm
CI-CAN-00000338Explore in graph →
Non-malignant3,042 active trials38 approved drugs197 evidence items
- NCIt
- C3674
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000338Explore in graph →
Clinical trials
13,672 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06437353 | Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer | recruiting | Phase 2 | 74 | Anhui Provincial Cancer HospitalOTHER | 1 | Nov 27, 2024 | clinicaltrials |
| NCT06706921 | 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer | recruiting | Phase 4 | 15 | VA Greater Los Angeles Healthcare SystemFED | 1 | Nov 27, 2024 |
| clinicaltrials |
| NCT05393791 | Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC(ANZadapt) | recruiting | Phase 2 | 168 | Leiden University Medical CenterOTHER | 2 | Nov 26, 2024 | clinicaltrials |
| NCT06603506 | Collection of Endometrial Cancer-derived Organoids to Evaluate the Efficacy of PARP Inhibitors: PENDOR Pilot Study(PENDOR) | recruiting | — | 16 | Centre Francois BaclesseOTHER | 1 | Nov 26, 2024 | clinicaltrials |
| NCT05824975 | A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) | recruiting | Phase 1 / Phase 2 | 358 | GI Innovation, Inc.INDUSTRY | 2 | Nov 25, 2024 | clinicaltrials |
| NCT05927818 | Sentinel Lymph Node Biopsy in Early-Stage Ovarian Cancer | recruiting | N/A | 100 | Istanbul UniversityOTHER | 1 | Nov 25, 2024 | clinicaltrials |
| NCT06692166 | A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Cancer | recruiting | Phase 3 | 420 | Mabwell (Shanghai) Bioscience Co., Ltd.INDUSTRY | 1 | Nov 22, 2024 | clinicaltrials |
| NCT02754115 | An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy | recruiting | — | 400 | Tata Memorial CentreOTHER | 1 | Nov 21, 2024 | clinicaltrials |
| NCT05933876 | The Impact of Radiotherapy on Oligometastatic Cancer | recruiting | — | 2,000 | Institut Investigacio Sanitaria Pere VirgiliOTHER | 1 | Nov 18, 2024 | clinicaltrials |
| NCT05656573 | CART-PSMA Cells for Advanced Prostate Cancer | recruiting | Phase 1 | 20 | Nova Therapeutics LLCINDUSTRY | 1 | Nov 15, 2024 | clinicaltrials |
| NCT05694208 | The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life | recruiting | N/A | 84 | Istanbul University - CerrahpasaOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06027892 | Two-fraction Versus Five-fraction Stereotactic Radiotherapy for Localized Prostate Cancer(SABR-Dual) | recruiting | N/A | 562 | Rabin Medical CenterOTHER | 1 | Nov 15, 2024 | clinicaltrials |
| NCT06686043 | HPV Vaccine, Imiquimod, and Metformin Combination Trial(HPV-VIM) | recruiting | Phase 2 | 85 | Baylor College of MedicineOTHER | 1 | Nov 13, 2024 | clinicaltrials |
| NCT06665932 | Stereotactic Radiotherapy of Prostate Cancer With Reduction of Safety Margins | recruiting | N/A | 100 | University Hospital OstravaOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06681259 | Clinical Specialty Queue For Gestational Trophoblastic Neoplasia | recruiting | — | 1,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06683066 | Study on Human Bioequivalence of Triprerelin Acetate for Injection | recruiting | Phase 1 | 120 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06685562 | The 4D PICTURE Project: Evaluating Metro Mapping As a Method to Support Shared Decision Making in Oncology | recruiting | — | 500 | Leiden University Medical CenterOTHER | 3 | Nov 12, 2024 | clinicaltrials |
| NCT06680791 | Molecular Classification in Relation to Prevention of Endometrial Cancer Recurrence and Lifestyle Factors(MPEC) | recruiting | — | 280 | Lukas VanekOTHER_GOV | 1 | Nov 8, 2024 | clinicaltrials |
| NCT05001477 | Customized TULSA-PRO Ablation Registry(CARE) | recruiting | — | 1,000 | Profound Medical Inc.OTHER | 1 | Nov 6, 2024 | clinicaltrials |
| NCT06579417 | ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer(ART-Pro) | recruiting | — | 500 | University of California, San DiegoOTHER | 2 | Nov 6, 2024 | clinicaltrials |
| NCT06289062 | Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer | recruiting | Phase 2 | 40 | Tongji HospitalOTHER | 1 | Nov 5, 2024 | clinicaltrials |
| NCT06672497 | Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients | recruiting | — | 30 | University of South CarolinaOTHER | 1 | Nov 4, 2024 | clinicaltrials |
| NCT06288373 | Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC | recruiting | Phase 2 / Phase 3 | 440 | Tongji HospitalOTHER | 1 | Oct 30, 2024 | clinicaltrials |
| NCT05403554 | A Study of NI-1801 in Patients with Mesothelin Expressing Solid Cancers | recruiting | Phase 1 | 70 | Light Chain Bioscience - Novimmune SAINDUSTRY | 2 | Oct 29, 2024 | clinicaltrials |
| NCT06416748 | Minimally Invasive Simple Hysterectomy in Low Risk Cervical Cancer(LASH) | recruiting | N/A | 974 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06663007 | RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure | recruiting | Phase 1 / Phase 2 | 72 | Tianjin Medical University Second HospitalOTHER | 1 | Oct 29, 2024 | clinicaltrials |
| NCT06416150 | Reducing Urban Cervical Cancer Disparities | recruiting | N/A | 546 | Fox Chase Cancer CenterOTHER | 1 | Oct 26, 2024 | clinicaltrials |
| NCT06584279 | Diagnostic Value of MRI-targeted Plus Index-lesion-ipsilaterally Systematic Biopsy for Biopsy-naive Men At Risk of Prostate Cancer | recruiting | — | 563 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06617481 | PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence | recruiting | Phase 2 | 30 | AdventHealthOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06656949 | Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer(SLN-EC-01) | recruiting | N/A | 42 | Qilu Hospital of Shandong UniversityOTHER | 1 | Oct 24, 2024 | clinicaltrials |
| NCT06614790 | Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.(NIRAPARIB) | recruiting | — | 300 | Pomeranian Medical University SzczecinOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT06655259 | Combination of TURP and Standard Systemic Therapy for MPCa(CTUSMEP01) | recruiting | Phase 2 | 200 | Fudan UniversityOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT06655506 | Enhanced Recovery Protocols in Gynecologic Oncology(ERGO) | recruiting | — | 600 | National and Kapodistrian University of AthensOTHER | 1 | Oct 23, 2024 | clinicaltrials |
| NCT05558007 | Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients | recruiting | Phase 2 | 72 | Biozeus Biopharmaceutical S.A.INDUSTRY | 1 | Oct 22, 2024 | clinicaltrials |
| NCT06522828 | A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients | recruiting | Phase 2 | 80 | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.INDUSTRY | 1 | Oct 21, 2024 | clinicaltrials |
| NCT06620016 | Circulating microRNAs in Small Testicular Masses and Retroperitoneal Post-chemotherapy Residual Masses.(SEARCH-1) | recruiting | — | 60 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | Oct 21, 2024 | clinicaltrials |
| NCT06636682 | FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer | recruiting | Phase 2 | 100 | Cellvax Therapeutics IncINDUSTRY | 1 | Oct 21, 2024 | clinicaltrials |
| NCT04921527 | Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer(CHIPRO) | recruiting | Phase 3 | 454 | Chipscreen Biosciences, Ltd.INDUSTRY | 1 | Oct 18, 2024 | clinicaltrials |
| NCT05629494 | Anti-inflammatory Drugs and Serum Prostate-Specific Antigen Test(ADAPT-PSA) | recruiting | Phase 4 | 198 | Albany Medical CollegeOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT06274892 | Remote Monitoring of Patient Reported Outcomes to Improve the Efficacy of the Acute Phase Radiotherapy Review Process(PROMOTE) | recruiting | N/A | 124 | University Health Network, TorontoOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT06644248 | AI Model for Cervical Cancer Detection From Colposcopy Images | recruiting | — | 500 | Bangladesh University of Engineering and TechnologyOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT06632431 | Clinicopathological Analysis of Endometrial Carcinoma in the View of Old and New International Federation of Gynecology and Obestetrics (FIGO) | recruiting | — | 110 | Assiut UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06636747 | High Resolution Diffusion Weighted Imaging in Prostate | recruiting | — | 500 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06637267 | Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau | recruiting | — | 480 | Kantonsspital AarauOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06638593 | MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.(MIRRORS-FROZEN) | recruiting | N/A | 40 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Oct 15, 2024 | clinicaltrials |
| NCT06640348 | Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer | recruiting | — | 70 | Anhui Provincial HospitalOTHER_GOV | 1 | Oct 15, 2024 | clinicaltrials |
| NCT05129605 | Prostate Cancer Genetic Risk Evaluation and Screening Study(PROGRESS) | recruiting | — | 400 | Massachusetts General HospitalOTHER | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06619626 | Alveolar Recruitment in Obese Patients in Major Gynaecological Cancer Surgery | recruiting | — | 40 | Bakirkoy Dr. Sadi Konuk Research and Training HospitalOTHER_GOV | 1 | Oct 9, 2024 | clinicaltrials |
| NCT06630962 | Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care(COST-FIN) | recruiting | N/A | 200 | Northwestern UniversityOTHER | 1 | Oct 8, 2024 | clinicaltrials |
| NCT05974995 | Robotic-assisted Versus Conventional Laparoscopic Surgery in Obese Patients With Early Endometrial Cancer(RObese) | recruiting | N/A | 566 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Oct 3, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Nov 27, 2024source: clinicaltrials